14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

NYMX Predictions History

4 years ago
NameNotImportant predicted that NYMX for 2019-05-06 is going $1.79 (-1.10%)

6 years ago
JS predicted that NYMX for 2017-06-05 is going $4.09 (-0.73%)

6 years ago
Jon predicted that NYMX for 2017-06-05 is going $3.96 (-3.88%)

6 years ago
JuanC Villegas predicted that NYMX for 2017-06-05 is going $4.06 (-1.46%)

6 years ago
Ruwently.Coffie.7636 predicted that NYMX for 2017-06-05 is going $4.08 (-0.97%)

Rank:

6 years ago
JS predicted that NYMX for 2017-06-01 is going $4.42 (5.24%)

7 years ago
Abdu predicted that NYMX for 2016-11-21 is going $3.11 (3.32%)

7 years ago
JS predicted that NYMX for 2016-11-21 is going $3.04 (1.00%)

7 years ago
StockVader predicted that NYMX for 2016-09-22 is going $3.54 (3.21%)

7 years ago
PumpTheseNumbers predicted that NYMX for 2016-09-22 is going $3.62 (5.54%)

Click to get the best stock tips daily for free!

About Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinica... NYMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT